SAMINI KEYVAN 4

4 · MOBIX LABS, INC · Filed Jun 15, 2026

AI-generated summary of this filing

Updated Jun 16, 2026

MOBIX LABS (MOBX) President Samini Keyvan Sells Shares

What Happened

Samini Keyvan, President, CFO and a director of MOBIX LABS, sold a total of 112,113 shares in open-market transactions. On 2026-06-11 he sold 3 shares at about $2.14 each (≈ $6). On 2026-06-12 he sold 112,110 shares at a weighted average price of $1.98 (≈ $222,056). Combined proceeds were approximately $222,062. These transactions are sales (code S), which are typically routine disposals rather than purchases that signal increased insider confidence.

Key Details

Transaction dates and prices:
- 2026-06-11: 3 shares sold; weighted avg price reported $2.14; prices in that tranche ranged $2.13–$2.14 (Footnote F1).
- 2026-06-12: 112,110 shares sold; weighted avg price reported $1.98; prices in that tranche ranged $1.9501–$2.1739 (Footnote F2).
Total shares sold: 112,113 for approximately $222,062 in proceeds.
Shares owned after transaction: not specified in the provided excerpt of the filing.
Filing/timeliness: Form 4 was filed on 2026-06-15 covering trades on 6/11–6/12. Form 4s are generally due within 2 business days of the transaction; this filing was submitted several days after the trades (check the full filing for any explanation).
Notable disclosures:
- Footnote F3 notes the reporting person is a trustee of a trust and disclaims beneficial ownership except to the extent of pecuniary interest.
- The filing notes a 1-for-10 reverse stock split effective April 6, 2026; reported share amounts and option exercise prices have been adjusted accordingly (Remarks).
- Footnotes F4 and F5 in the filing describe option vesting and conversion rights for certain share classes (see full filing for details).

Context

Sales by executives can be for many reasons (liquidity, diversification, tax, etc.) and do not necessarily indicate a change in insider view on the company. These were outright sales (not option exercises or gifts).
If you want the exact breakdown of how many shares traded at each individual price within the ranges, the filer indicates they will provide that detail to the SEC or issuer upon request (per footnotes).

Form 4

Period: 2026-06-11

DirectorPresident, CFO & Director

Transactions

Sale
Class A Common Stock
[F1]
2026-06-11$2.14/sh−3$6→ 267,163 total
Sale
Class A Common Stock
[F2]
2026-06-12$1.98/sh−112,110$222,056→ 155,053 total

Holdings

Class A Common Stock
[F3]
(indirect: By Trust)
7,353
Class A Common Stock
[F3]
(indirect: By Trust)
17,114
Class A Common Stock
[F3]
(indirect: By Trust)
7,352
Option (Right to Buy)
[F4]
Exercise: $1.70Exp: 2030-08-10→ Class A Common Stock (32,353 underlying)
32,352
Class B Common Stock
[F5][F3]
(indirect: By Trust)
→ Class A Common Stock (12,500 underlying)
12,500

Footnotes (5)

[F1]Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions range from $2.13 to $2.14 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or the security holder of the issuer full information regarding the number of shares sold at each separate price.
[F2]Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions range from $1.9501 to $2.1739 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or the security holder of the issuer full information regarding the number of shares sold at each separate price.
[F3]The Reporting Person is a trustee of this trust. The Reporting Person disclaims beneficial ownership of the securities held by this trust except to the extent of his respective pecuniary interest therein.
[F4]These options are fully vested and exercisable.
[F5]The shares of Class B Common Stock are convertible into shares of Class A Common Stock at the option of the Reporting Person and will be automatically converted upon (i) a transfer by the Reporting Person (other than a permitted transfer) or (ii) the first trading day after the seventh anniversary date of the Closing Date (December 21, 2023).

Signature

/s/ Terri Aprati, Attorney-in-Fact|2026-06-15

1 file